PMID- 28254639
OWN - NLM
STAT- MEDLINE
DCOM- 20170921
LR  - 20191210
IS  - 1532-821X (Electronic)
IS  - 0003-9993 (Linking)
VI  - 98
IP  - 9
DP  - 2017 Sep
TI  - Psychometric and Clinimetric Properties of the Melbourne Assessment 2 in Children 
      With Cerebral Palsy.
PG  - 1836-1841
LID - S0003-9993(17)30097-7 [pii]
LID - 10.1016/j.apmr.2017.01.024 [doi]
AB  - OBJECTIVE: To examine the psychometric and clinimetric properties of the 
      Melbourne Assessment 2 (MA2), an outcome measurement that is increasingly used in 
      clinical studies. DESIGN: Psychometric and clinimetric study. SETTING: Community. 
      PARTICIPANTS: Seventeen children with cerebral palsy (CP) from 5 to 12 years were 
      recruited for the estimation of the test-retest reliability and minimal 
      detectable change (MDC). Thirty-five children with CP were recruited to receive 
      an 8-week intensive neurorehabilitation intervention to estimate the validity, 
      responsiveness, and minimal clinically important difference (MCID). 
      INTERVENTIONS: Thirty-five children with CP received upper limb 
      neurorehabilitation programs for 8 weeks. MAIN OUTCOME MEASURES: The MA2 and the 
      criterion measures, including the Bruininks-Oseretsky Test of Motor Proficiency, 
      2nd edition (BOT-2), the Box and Blocks Test (BBT), and the Pediatric Motor 
      Activity Log-Revised (PMAL-R), were evaluated at pretreatment and posttreatment. 
      RESULTS: The MA2 has 4 subscales: range of motion, fluency, accuracy, and 
      dexterity. The test-retest reliability of the MA2 is high (intraclass correlation 
      coefficient, .92-.98). The significant relationships between the MA2 and BBT, 
      BOT-2, and PMAL-R support its validity. The significance of paired t test results 
      (P<.001) and large magnitudes of the standardized response mean (1.70-2.00) 
      confirm the responsiveness of the MA2. The MDC values of the 4 subscales of the 
      MA2 are 2.85, 1.63, 1.97, and 1.84, respectively, and the suggested MCID values 
      of these 4 subscales are 2.35, 3.20, 2.09, and 2.22, respectively, indicating the 
      minimum scores of improvement to be interpreted as both statistically significant 
      and clinically important. CONCLUSIONS: The study findings indicate that the MA2 
      has sound psychometric and clinimetric properties and is thus an adequate 
      measurement for research and clinical applications.
CI  - Copyright (c) 2017 American Congress of Rehabilitation Medicine. Published by 
      Elsevier Inc. All rights reserved.
FAU - Wang, Tien-Ni
AU  - Wang TN
AD  - School of Occupational Therapy, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
FAU - Liang, Kai-Jie
AU  - Liang KJ
AD  - School of Occupational Therapy, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
FAU - Liu, Yi-Chia
AU  - Liu YC
AD  - School of Occupational Therapy, College of Medicine, National Taiwan University, 
      Taipei, Taiwan.
FAU - Shieh, Jeng-Yi
AU  - Shieh JY
AD  - Department of Physical Medicine and Rehabilitation, National Taiwan University 
      Hospital, Taipei, Taiwan.
FAU - Chen, Hao-Ling
AU  - Chen HL
AD  - School of Occupational Therapy, College of Medicine, National Taiwan University, 
      Taipei, Taiwan. Electronic address: hlchen@ntu.edu.tw.
LA  - eng
PT  - Journal Article
PT  - Validation Study
DEP - 20170228
PL  - United States
TA  - Arch Phys Med Rehabil
JT  - Archives of physical medicine and rehabilitation
JID - 2985158R
SB  - IM
MH  - Cerebral Palsy/*psychology/*rehabilitation
MH  - Child
MH  - Child, Preschool
MH  - *Disability Evaluation
MH  - Female
MH  - Humans
MH  - Male
MH  - *Minimal Clinically Important Difference
MH  - Neurological Rehabilitation/methods/statistics & numerical data
MH  - Psychometrics
MH  - Reproducibility of Results
MH  - Treatment Outcome
MH  - Upper Extremity
MH  - Victoria
OTO - NOTNLM
OT  - Cerebral palsy
OT  - Minimal clinically important difference
OT  - Psychometrics
OT  - Rehabilitation
OT  - Reproducibility of results
EDAT- 2017/03/04 06:00
MHDA- 2017/09/22 06:00
CRDT- 2017/03/04 06:00
PHST- 2016/09/01 00:00 [received]
PHST- 2017/01/01 00:00 [revised]
PHST- 2017/01/23 00:00 [accepted]
PHST- 2017/03/04 06:00 [pubmed]
PHST- 2017/09/22 06:00 [medline]
PHST- 2017/03/04 06:00 [entrez]
AID - S0003-9993(17)30097-7 [pii]
AID - 10.1016/j.apmr.2017.01.024 [doi]
PST - ppublish
SO  - Arch Phys Med Rehabil. 2017 Sep;98(9):1836-1841. doi: 10.1016/j.apmr.2017.01.024. 
      Epub 2017 Feb 28.